Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;162(5):e284-e285.
doi: 10.1016/j.chest.2022.07.028.

COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON

Arturo Casadevall  1 , Jeffrey P Henderson  2
Affiliations
Comment

COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON

Arturo Casadevall et al. Chest. 2022 Nov.
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Self WH, Wheeler AP, Chappell JD, Thomsen I, Pulley JM, Rhoads JP, Bernard GR, Rice TW. Self WH, et al. Chest. 2022 Nov;162(5):e285-e287. doi: 10.1016/j.chest.2022.08.2204. Chest. 2022. PMID: 36344144 Free PMC article. No abstract available.

Comment on

  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
    Self WH, Wheeler AP, Stewart TG, Schrager H, Mallada J, Thomas CB, Cataldo VD, O'Neal HR Jr, Shapiro NI, Higgins C, Ginde AA, Chauhan L, Johnson NJ, Henning DJ, Jaiswal SJ, Mammen MJ, Harris ES, Pannu SR, Laguio-Vila M, El Atrouni W, de Wit M, Hoda D, Cohn CS, McWilliams C, Shanholtz C, Jones AE, Raval JS, Mucha S, Ipe TS, Qiao X, Schrantz SJ, Shenoy A, Fremont RD, Brady EJ, Carnahan RH, Chappell JD, Crowe JE Jr, Denison MR, Gilchuk P, Stevens LJ, Sutton RE, Thomsen I, Yoder SM, Bistran-Hall AJ, Casey JD, Lindsell CJ, Wang L, Pulley JM, Rhoads JP, Bernard GR, Rice TW; Passive Immunity Trial for Our Nation (PassITON) Investigators. Self WH, et al. Chest. 2022 Nov;162(5):982-994. doi: 10.1016/j.chest.2022.06.029. Epub 2022 Jul 1. Chest. 2022. PMID: 35780813 Free PMC article. Clinical Trial.

References

    1. Self W.H., Wheeler A.P., Stewart T.G., et al. Neutralizing COVID-19 convalescent plasma in adults hospitalized with COVID-19: a blinded, randomized, placebo-controlled trial. Chest. 2022;162(5):982–994. - PMC - PubMed
    1. Marconato M., Abela I.A., Hauser A., et al. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response. J Clin Invest. 2022;132(12):e158190. - PMC - PubMed
    1. Ortigoza M.B., Yoon H., Goldfeld K.S., et al. Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial. JAMA Intern Med. 2022;82(2):115–126. - PMC - PubMed
    1. O’Donnell M.R., Grinsztejn B., Cummings M.J., et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. . 2021;131(13) - PMC - PubMed
    1. Plummer N., Liebmann J., Solomon S., Kammerer W., Kalkstein M., Ensworth H.K. Chemotherapy versus combined chemotherapy and serum: in the treatment of pneumonia a study of 607 alternated cases. JAMA. 1941;116(21):2366–2367.

LinkOut - more resources